RP
NTLA icon

Regeneron Pharmaceuticals’s Intellia Therapeutics NTLA Stock Holding History

Regeneron Pharmaceuticals’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$34.7M Hold
3,702,995
– – 2.34% 2
2025
Q1 		$26.3M Hold
3,702,995
– – 2.13% 2
2024
Q4 		$43.2M Buy
+3,702,995
New +$43.2M 3.94% 2